ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference
2021年11月6日 - 6:00AM
ビジネスワイヤ(英語)
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence
and clinical research organisation, today announced that Mr.
Brendan Brennan, CFO of ICON plc, will present at:
- the 30th Annual Credit Suisse Healthcare Conference on Tuesday,
November 9, 2021 at 8.50am ET; and
- the 4th Annual Evercore ISI HealthCONx Conference on Wednesday,
December 1, 2021 at 12:10pm ET.
Any changes to these events and links to the live webcasts
(where available) will be posted on the Investor section of our
website under “Events”.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 37,960 employees in 159
locations in 53 countries as at September 30, 2021. For further
information about ICON, visit: www.iconplc.com and
www.iconplc.com/pra.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, the impact of
COVID-19 on our business, as well as other economic and global
market conditions and other risks and uncertainties detailed from
time to time in SEC reports filed by ICON, all of which are
difficult to predict and some of which are beyond our control. For
these reasons, you should not place undue reliance on these
forward-looking statements when making investment decisions. The
word "expected" and variations of such words and similar
expressions are intended to identify forward-looking statements.
Forward-looking statements are only as of the date they are made
and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information,
future events or otherwise. More information about the risks and
uncertainties relating to these forward-looking statements may be
found in SEC reports filed by ICON, including its Form 20-F, F-1,
F-4, S-8, F-3 and certain other reports, which are available on the
SEC's website at http://www.sec.gov.
Source: ICON plc
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211105005836/en/
Kate Haven Vice President Investor Relations +1888 381 7923
ICON (NASDAQ:ICLR)
過去 株価チャート
から 6 2024 まで 7 2024
ICON (NASDAQ:ICLR)
過去 株価チャート
から 7 2023 まで 7 2024